11th National Ayurveda Day 2026: Theme 'Ayurveda for a Healthier Tomorrow', Key Initiatives and India's AYUSH Expansion

Why in News

India observed the 11th National Ayurveda Day on September 23, 2026, with the theme "Ayurveda for a Healthier Tomorrow" (Hindi: स्वस्थ भविष्य के लिए आयुर्वेद). The main national event was held in Nagpur, Maharashtra, with Union Minister of State for Ayush Prataprao Jadhav as the key spokesperson. The Ministry of Ayush used the occasion to release the Ayush Vision 2030 strategic document and present the National Dhanwantari Ayurveda Awards 2026. Medicinal plant safety dossiers for farmers were also unveiled at a curtain-raiser press conference at the National Media Centre, New Delhi.

Background

National Ayurveda Day was first observed in 2016, coinciding with Dhanvantari Jayanti — the birth anniversary of the divine physician Dhanvantari in Hindu tradition — which falls on Dhanteras (Trayodashi of the Kartik month in the lunar calendar). This date varied each year, creating scheduling and programming challenges for national and international events.

In March 2025, the Government of India issued a Gazette Notification permanently fixing September 23 — the autumnal equinox — as the annual date for National Ayurveda Day. The autumnal equinox symbolically represents nature's equilibrium (equal day and night), aligned with Ayurveda's core philosophy of tridosha balance (Vata, Pitta, Kapha). The new date also coincides with the UN General Assembly High-Level Week, enabling India to showcase its traditional medicine achievements on global platforms.

Timeline of Key Milestones

Current Developments

The Ministry of Ayush released the Ayush Vision 2030 — a forward-looking strategic roadmap for the sector — at the 11th Ayurveda Day celebrations. The document charts targets for expanding Ayurveda's global footprint, integrating traditional medicine into the mainstream healthcare delivery system, and building a robust science-backed regulatory framework.

The National Dhanwantari Ayurveda Awards 2026 were presented to three individuals who made outstanding contributions in Ayurvedic research, clinical practice, and innovation. Each award consists of a cash prize of ₹5 lakh, a citation, and a trophy (a statue of Dhanvantari). The awards are administered by the Central Council for Research in Ayurvedic Sciences (CCRAS). Medicinal plant safety dossiers — technical documents standardising cultivation, harvesting, and quality-control practices — were also launched to integrate farming communities into the formal AYUSH supply chain.

Key Facts

• 2026 Theme: "Ayurveda for a Healthier Tomorrow"
• Permanent date: September 23 (autumnal equinox), via Gazette Notification, March 2025
• Edition: 11th National Ayurveda Day (first observed 2016)
• AYUSH full form: Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homoeopathy
• Ministry of Ayush formed: November 9, 2014
• AYUSH Budget 2026-27: ₹4,408 crore
• Registered AYUSH practitioners (Dec 2024): 7,55,780 total; Ayurveda alone: over 3,55,000
• Ayurveda colleges: 593
• Ayushman Arogya Mandirs (functional): 12,260 (target: 12,500)
• AYUSH exports (2024-25): USD 688.89 million (6.11% year-on-year growth) to 150+ countries
• Country-to-country AYUSH MoUs: 27
• Ayush Information Cells globally: 46 across 43 countries; 104 scholarships for foreign nationals annually
• National Dhanwantari Ayurveda Award: 3 awards/year; ₹5 lakh each; administered by CCRAS

Constitutional Provisions

Article 47 (Part IV — Directive Principles of State Policy) mandates: "The State shall regard the raising of the level of nutrition and the standard of living of its people and the improvement of public health as among its primary duties." This is the primary constitutional basis for the Government's promotion of traditional medicine systems under AYUSH.

Entry 19, List II (State List), Seventh Schedule covers "public health and sanitation," empowering states to maintain their own AYUSH departments, hospitals, dispensaries, and integrate traditional practitioners into state health systems. This concurrent responsibility explains the large number of state-run Ayurveda hospitals and dispensaries across India.

Legal Framework

• Indian Medicine Central Council Act, 1970: Established the Central Council of Indian Medicine (CCIM), the predecessor regulatory body for Ayurveda, Unani, and Siddha education. It set minimum educational standards, maintained a central register, and governed college recognition.
• National Commission for Indian System of Medicine Act, 2020: Replaced CCIM with the National Commission for Indian System of Medicine (NCISM). Key reforms: standardised and transparent admissions, a common exit examination, and merit-based faculty appointments.
• Drugs and Cosmetics Act, 1940 — Chapter IVA: Governs manufacture, sale, and distribution of Ayurvedic, Siddha, and Unani (ASU) drugs. Defines "patent or proprietary medicines" in the AYUSH sector and empowers licensing authorities in states.
• Ayurvedic Pharmacopoeia of India (API): Official compendium of standards for Ayurvedic single drugs and formulations, maintained by the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIMH).

Institutional Framework

The Ministry of Ayush is the nodal ministry for all six AYUSH systems. Key bodies include:

• National Commission for Indian System of Medicine (NCISM): Regulates Ayurveda, Unani, and Siddha undergraduate and postgraduate education.
• Central Council for Research in Ayurvedic Sciences (CCRAS): Apex body for research in Ayurveda; administers National Dhanwantari Ayurveda Awards.
• Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIMH): Develops pharmacopoeia standards for quality assurance.
• National Medicinal Plants Board (NMPB): Governs conservation, cultivation, and sustainable use of medicinal plants.
• All India Institute of Ayurveda (AIIA), New Delhi: The apex clinical and research institution, akin to an AIIMS for Ayurveda.

At the international level, the WHO Global Centre for Traditional Medicine (GCTM), Jamnagar, Gujarat — the first and only such WHO centre worldwide — positions India as the global hub for evidence-based traditional medicine research and standardisation. India's inclusion of Ayurveda in WHO ICD-11 enables standardised disease coding and insurance processing globally.

Economic Dimensions

The AYUSH sector is one of India's fastest-growing healthcare sub-sectors. The AYUSH Budget 2026-27 stands at ₹4,408 crore, funding three new All India Institutes of Ayurveda, pharmacy upgrades, and testing laboratories.

India's AYUSH exports reached USD 688.89 million in 2024-25 (6.11% year-on-year growth) and have cumulatively reached USD 2.16 billion over the decade 2014–2023, reaching 150+ countries. The domestic AYUSH market — encompassing herbal medicines, supplements, cosmetics, and wellness services — is estimated at over ₹1,00,000 crore. Post-pandemic wellness trends and rising global interest in preventive and integrative healthcare are major demand drivers.

The National AYUSH Mission (NAM) and PM Mudra scheme support AYUSH-based micro-enterprises, particularly in herbal product manufacturing, creating livelihoods especially in tribal and rural belts where medicinal plant cultivation is traditional.

Environmental Dimensions

The National Medicinal Plants Board (NMPB) works at the intersection of AYUSH promotion and biodiversity conservation. India's forests and biodiversity hotspots — particularly the Western Ghats, Eastern Himalayas, and North-East — are major repositories of medicinal flora. Over-harvesting of wild medicinal plants poses a significant biodiversity threat.

The 2026 launch of medicinal plant safety dossiers aims to shift sourcing from wild collection to sustainable cultivation under WHO Good Agricultural and Collection Practices (GACP) standards. This balances commercial demand with species conservation, aligning with India's commitments under the Convention on Biological Diversity (CBD) and the Kunming-Montreal Global Biodiversity Framework.

Social Dimensions

AYUSH systems play a disproportionately large role in rural, tribal, and remote area healthcare where modern medical infrastructure is often unavailable. The integration of AYUSH practitioners into Ayushman Arogya Mandirs (12,260 functional) extends primary care to the last mile under the Universal Health Coverage (UHC) vision.

Women constitute a significant share of AYUSH practitioners — particularly in Yoga, naturopathy, and Ayurveda nursing — and represent a large consumer base. Maternal health, child nutrition, and menstrual wellness are priority areas in integrative AYUSH healthcare programmes.

Tribal communities, many of whom are traditional practitioners (Vaidyas), are being integrated into the formal AYUSH supply chain through the NMPB's cultivation support and the new medicinal plant safety dossiers, providing income diversification and preserving endangered traditional knowledge.

International Relations

India holds 27 bilateral AYUSH MoUs with foreign governments and operates 46 Ayush Information Cells across 43 countries. The WHO GCTM in Jamnagar — the first and only global centre for traditional medicine — is India's flagship multilateral achievement in health diplomacy.

The inclusion of Ayurveda in WHO ICD-11 (effective January 2022) is a watershed development: it enables global insurers to reimburse Ayurveda treatments, standardises clinical research protocols, and positions Indian institutions as global referral centres for traditional medicine training and research.

India provides 104 AYUSH scholarships annually to foreign nationals, building goodwill and expanding Ayurveda's global practitioner base. This forms part of India's broader health diplomacy agenda alongside vaccine maitri and ITEC (Indian Technical and Economic Cooperation) partnerships.

Challenges

• Standardisation gap: Significant variability in raw material quality, formulation standards, and clinical protocols undermines reproducibility, safety, and global credibility.
• Thin evidence base: Limited high-quality randomised controlled trials (RCTs) for key Ayurvedic interventions hampers acceptance in mainstream evidence-based medicine.
• Heavy metal concerns: Classical formulations containing processed metals (bhasmas) face export restrictions in European and US markets due to heavy metal content thresholds.
• Unregistered practitioners: A large informal sector of undertrained and unregistered practitioners operates outside regulatory oversight, posing patient safety risks.
• Integration barriers: Professional and conceptual tensions between allopathic (modern) medicine and AYUSH systems slow the integrative healthcare model, especially in tertiary hospital settings.
• Over-harvesting of medicinal plants: Commercial demand is depleting wild medicinal plant populations, threatening both biodiversity and the raw material supply chain.

Government Initiatives

• National AYUSH Mission (NAM): Centrally Sponsored Scheme for strengthening AYUSH infrastructure, colleges, research, quality control, and insurance coverage.
• Ayushman Arogya Mandirs: AYUSH wellness centres co-located with Primary Health Centres (PHCs) and Health and Wellness Centres (HWCs) under Ayushman Bharat, delivering preventive and promotive care.
• WHO GCTM, Jamnagar: India hosts the world's only WHO Global Centre for Traditional Medicine, providing global leadership in evidence generation, standardisation, and regulation of traditional medicine.
• Ayush Vision 2030: Strategic roadmap released at the 11th Ayurveda Day (September 23, 2026) charting the sector's medium-term growth, regulatory, and global engagement goals.
• Medicinal Plant Safety Dossiers: Technical documents launched in 2026 to standardise cultivation, harvesting, and quality control, integrating farmers and tribal communities into the formal AYUSH supply chain.

Way Forward

The NITI Aayog's reports on healthcare universalisation and the Economic Survey's emphasis on human capital investment both highlight the untapped potential of AYUSH in expanding affordable primary healthcare. Key recommendations:

• Developing mandatory, CCRAS-led evidence-based clinical practice guidelines for high-prevalence conditions treated with Ayurveda, through multi-centre randomised trials.
• Adopting WHO GACP standards for all medicinal plant sourcing and achieving EU-GMP compliance for major Ayurvedic export formulations to unlock premium global markets.
• Completing the rollout of 12,500 Ayushman Arogya Mandirs with qualified AYUSH practitioners to achieve last-mile Universal Health Coverage, particularly in tribal blocks.
• Leveraging India's bilateral FTA negotiations (with UAE, UK, EU, and GCC) to secure Mutual Recognition Agreements (MRAs) for AYUSH services and practitioners, enabling service exports.
• Establishing a National Ayurveda Digital Registry for interoperable tracking of practitioners, clinical outcomes, and adverse events — an essential quality and pharmacovigilance infrastructure.

Possible Mains Questions

1. "Traditional medicine systems like Ayurveda are increasingly recognised globally, yet their integration into India's mainstream healthcare remains limited. Discuss the challenges and suggest a way forward." (GS-II, 250 words)
2. "Critically evaluate the role of the Ministry of Ayush in expanding India's healthcare outreach and soft power potential through traditional medicine diplomacy." (GS-II, 250 words)

Possible Prelims MCQs

1. Q: The autumnal equinox (September 23) was fixed as the permanent date for National Ayurveda Day through a Gazette Notification issued in which year?
   A) 2022   B) 2023   C) 2024   D) 2025   — Ans: D
2. Q: The WHO Global Centre for Traditional Medicine (GCTM), the world's only such centre, is located at:
   A) Pune, Maharashtra   B) Rishikesh, Uttarakhand   C) Jamnagar, Gujarat   D) Thiruvananthapuram, Kerala   — Ans: C
3. Q: Which body replaced the Indian Medicine Central Council (CCIM) for regulating Ayurveda, Unani, and Siddha education under the National Commission for Indian System of Medicine Act, 2020?
   A) CCRAS   B) NCISM   C) NMPB   D) AIIA   — Ans: B
4. Q: AYUSH in the Ministry of Ayush stands for Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homoeopathy. 'Sowa-Rigpa' refers to the traditional medicine system of which region?
   A) Kerala   B) Tamil Nadu   C) Ladakh/Tibet   D) Assam/North-East   — Ans: C
5. Q: With reference to the National Dhanwantari Ayurveda Awards, consider the following statements: (1) They are administered by the Central Council for Research in Ayurvedic Sciences (CCRAS). (2) The award carries a cash prize of ₹5 lakh. (3) The award is given to 10 practitioners each year. Which is/are correct?
   A) 1 and 2 only   B) 2 and 3 only   C) 1 only   D) 1, 2, and 3   — Ans: A (only 3 awards/year, not 10)

Essay Dimensions

1. Traditional knowledge as a pillar of India's soft power in global health diplomacy.
2. The science-tradition paradox: Can Ayurveda be evidence-based without losing its holistic character?
3. Universal Health Coverage in a developing country: the role of pluralistic medicine systems.
4. Medicinal plants, farmers' livelihoods, and biodiversity conservation — a triangular nexus.
5. India's WHO leadership in traditional medicine: strategic implications for health multilateralism.

Interview Questions

1. Should Ayurveda practitioners be permitted to perform minor surgeries given their Shalya Tantra training? What regulatory safeguards would you require?
2. India hosts the only WHO Global Centre for Traditional Medicine. How can India translate this diplomatic capital into concrete global health influence?
3. How can AYUSH be leveraged as a vehicle for India's healthcare outreach in its neighbourhood policy (SAARC, ASEAN)?
4. There is growing concern about adulterated and mislabelled Ayurvedic products in export markets. What systemic regulatory solutions would you propose as Secretary, Ministry of Ayush?
5. Is the integration of AYUSH into Ayushman Bharat meaningful last-mile delivery, or does it risk diluting both systems? What does the evidence say?

FAQ

Why was National Ayurveda Day shifted to September 23 from Dhanvantari Jayanti?

A Gazette Notification of March 2025 permanently fixed September 23 (the autumnal equinox) as National Ayurveda Day, replacing the earlier Dhanvantari Jayanti (lunar calendar, falls on Dhanteras/Trayodashi of Kartik month) formula. The fixed solar date ensures consistent national and international scheduling, and symbolically reflects Ayurveda's philosophy of natural balance (equal day and night on the equinox). It also coincides with the UN General Assembly High-Level Week, enabling India's global AYUSH outreach.

What is the AYUSH Budget for 2026-27?

The Ministry of Ayush was allocated ₹4,408 crore in the Union Budget 2026-27, funding three new All India Institutes of Ayurveda, pharmacy infrastructure upgrades, and quality testing laboratories across India.

What is the WHO GCTM and why is it significant for India?

The WHO Global Centre for Traditional Medicine (GCTM) in Jamnagar, Gujarat, inaugurated in 2022, is the world's first and only WHO-designated global centre for traditional medicine. Hosted by India, it generates evidence, develops standards, and advises on policy for traditional medicine globally. Its establishment is a landmark in India's health diplomacy and positions Indian Ayurveda institutions as global referral centres for research and training.

Further Reading

• Ministry of Ayush: ayush.gov.in
• Central Council for Research in Ayurvedic Sciences: ccras.nic.in
• WHO Global Centre for Traditional Medicine: who.int/initiatives/who-global-centre-for-traditional-medicine
• WHO Traditional Medicine Strategy 2019–2025: who.int
• National Medicinal Plants Board: nmpb.nic.in